Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for thromboprophylaxis in cancer patients with ports
NCT04309240Phase 3Unknown
- Sponsor
- Liuzhou People's Hospital
- Start
- Mar 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rivaroxaban in venous thrombosis, sponsored by Liuzhou People's Hospital. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
venous thrombosis
Beyond the preview
Go deeper on NCT04309240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04309240.